Prism medico & pharmacy Limited has filed its quarterly compliance certificate with BSE Limited and Metropolitan Stock Exchange of India Limited (MSEI) for the quarter ended March 31, 2026. The submission fulfills regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Submission

The company submitted the confirmation certificate as mandated by Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The certificate was issued by Purva Sharegistry (India) Pvt. Ltd., which serves as the company's Registrar and Share Transfer Agent (RTA).

Share Dematerialization Activity

The detailed report covering the period from January 1, 2026 to March 31, 2026 shows no dematerialization activity during the quarter. The certificate confirms that no security certificates were received from depository participants for dematerialization during this period.

RTA Confirmation

Purva Sharegistry (India) Pvt. Ltd., a SEBI registered Category 1 Registrar and Share Transfer Agent, confirmed compliance with all regulatory requirements. The RTA verified that securities received for dematerialization are processed within prescribed timelines and that proper procedures are followed for certificate handling and member register updates.

Company Information

Prism Medico and Pharmacy Limited is registered in Himachal Pradesh with its office located at Suketi Road, Kala Amb, Sirmaur. The company's shares are listed on both BSE Limited and Metropolitan Stock Exchange of India Limited. Director Davender Singh signed the compliance submission on behalf of the company.

Prism Medico & Pharmacy Limited has submitted its mandatory annual disclosure under SEBI regulations, confirming that no promoter share encumbrances occurred during the financial year ended 31st March, 2026. The disclosure was filed with stock exchanges on 07.04.2026 as required under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Regulatory Compliance Details

The company filed identical disclosures with both BSE Limited and Metropolitan Stock Exchange of India Limited (MSEI), confirming compliance with substantial acquisition disclosure requirements. Director Davender Singh (DIN: 09447213) signed the company's submission to exchanges.

Promoter Confirmation

Symbiosis Pharmaceuticals Private Limited, acting as a promoter entity, provided written confirmation that no encumbrances were made on shares held by promoters and persons acting in concert during FY26. The confirmation was signed by authorized signatory Mr. Jagbir Singh on behalf of the promoter group.

Stock Exchange Submissions

The disclosures were submitted to both exchanges where the company's shares are listed:

Company Information

Prism Medico and Pharmacy Limited operates from its registered office at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030. The company maintains investor grievance communication through investorgrievancewmcl@gmail.com and continues to fulfill its regulatory disclosure obligations as a listed entity.

The annual disclosure represents standard compliance practice for listed companies, ensuring transparency regarding promoter shareholding patterns and any potential encumbrances that could affect shareholder interests.